NASDAQ$COO
The Cooper Companies Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Reported record revenues with CooperVision and CooperSurgical's fertility business showing strong organic revenue growth.
CooperCompanies announced its fiscal third quarter results with revenue increasing by 10% year-over-year to $843.4 million. CooperVision's revenue increased by 2% to $566.3 million, while CooperSurgical's revenue increased by 35% to $277.1 million. GAAP diluted earnings per share were $1.98, and non-GAAP diluted earnings per share were $3.19.
- Revenue increased 10% year-over-year to $843.4 million.
- CooperVision (CVI) revenue up 2% to $566.3 million.
- CooperSurgical (CSI) revenue up 35% to $277.1 million.
- Non-GAAP diluted earnings per share $3.19, down 6% from last year's third quarter.
Headline financials
Revenue & EPS history
Cooper · Revenue · Quarterly
$843M
Revenue by segment
Cooper · $277M total across 2 segments · Q3 2022
- Office and Surgical$165M+35.0%59.7%
- Fertility$112M+33.9%40.3%
Forward guidance
The Company updated its fiscal year 2022 financial guidance.
Tailwinds
- Fiscal 2022 total revenue $3,290 - $3,310 million (organic growth of 10% to 11%)
- CVI revenue $2,236 - $2,247 million (organic growth of 11% to 12%)
- CSI revenue $1,055 - $1,064 million (organic growth of 7% to 8%)
- Fiscal 2022 non-GAAP diluted EPS $12.72 - $12.87
- Fiscal fourth quarter 2022 total revenue $830 - $850 million (organic growth of 9% to 11%)
Headwinds
- CVI revenue $554 - $565 million (organic growth of 8% to 10%)
- CSI revenue $276 - $285 million (organic growth of 10% to 15%)
- Fiscal fourth quarter 2022 non-GAAP diluted EPS $3.05 - $3.20
- Fiscal year 2022 financial guidance does not include the Cook Medical Reproductive Health acquisition announced on February 7, 2022, as the transaction is pending regulatory approval.
- Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and other exceptional or unusual income or gains and charges or expenses including acquisition, integration and manufacturing related costs which we may incur as part of our continuing operations.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.5%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.1%
Avg return
30 days after
51%
35 / 68 earnings
Positive
+12.1%
Q3 2024
Best reaction
-12.8%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.6% | -8.0% | -12.5% | |
| Q4 2025 | -4.3% | +4.8% | +5.3% | |
| Q3 2025 | -12.8% | -11.8% | -8.9% | |
| Q2 2025 | +0.0% | -0.3% | +3.6% | |
| Q1 2025 | -6.6% | -13.1% | -18.9% | |
| Q4 2024 | -6.0% | -5.6% | -12.6% | |
| Q3 2024 | +12.1% | +12.1% | +16.4% | |
| Q2 2024 | +3.5% | +3.8% | -4.2% | |
| Q1 2024 | +8.1% | +7.3% | +7.4% | |
| Q4 2023 | -2.2% | -0.7% | +6.8% | |
| Q3 2023 | -2.1% | -3.5% | -15.9% | |
| Q2 2023 | -4.0% | -5.1% | +3.2% | |
| Q1 2023 | +8.7% | +3.9% | +15.4% | |
| Q4 2022 | -1.6% | +4.8% | +9.7% | |
| Q3 2022 | +4.1% | +2.5% | -8.5% | |
| Q2 2022 | -0.3% | +1.3% | -7.2% | |
| Q1 2022 | +2.1% | -8.5% | +3.1% | |
| Q4 2021 | +4.8% | +8.7% | +12.2% | |
| Q3 2021 | +1.1% | -0.7% | -7.6% | |
| Q2 2021 | -0.7% | -3.2% | +6.0% | |
| Q1 2021 | +1.8% | +0.3% | +1.1% | |
| Q4 2020 | +3.3% | +3.3% | +8.6% | |
| Q3 2020 | +2.0% | +0.3% | +5.7% | |
| Q2 2020 | -0.2% | -5.0% | -9.1% | |
| Q1 2020 | -1.3% | -0.9% | -17.3% | |
| Q4 2019 | -1.6% | -2.4% | +3.3% | |
| Q3 2019 | -3.5% | -6.7% | -8.3% | |
| Q2 2019 | +4.5% | +9.0% | +18.2% | |
| Q1 2019 | -1.8% | +0.1% | +1.0% | |
| Q4 2018 | -11.6% | -7.3% | -10.4% | |
| Q3 2018 | -3.7% | -3.4% | +4.3% | |
| Q2 2018 | +1.4% | -0.4% | +6.0% | |
| Q1 2018 | +2.1% | -3.8% | -11.5% | |
| Q4 2017 | -3.2% | -1.9% | -1.5% | |
| Q3 2017 | -4.0% | -2.5% | -3.7% | |
| Q2 2017 | +8.9% | +10.5% | +9.4% | |
| Q1 2017 | -3.1% | -3.6% | -0.4% | |
| Q4 2016 | +1.3% | +4.1% | +5.2% | |
| Q3 2016 | +0.0% | +1.3% | -3.6% | |
| Q2 2016 | -0.1% | -0.4% | +7.1% | |
| Q1 2016 | +6.4% | — | — | |
| Q4 2015 | -12.8% | — | — | |
| Q3 2015 | -7.1% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | +9.7% | — | — | |
| Q4 2014 | -4.4% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.7% | — | — | |
| Q1 2014 | +4.3% | — | — | |
| Q4 2013 | -4.6% | — | — | |
| Q3 2013 | -1.8% | — | — | |
| Q2 2013 | +8.1% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.3% | — | — | |
| Q2 2012 | -4.1% | — | — | |
| Q1 2012 | +2.8% | — | — | |
| Q4 2008 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q2 2011 | +1.4% | — | — | |
| Q2 2010 | +1.4% | — | — | |
| Q1 2010 | +8.9% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q3 2010 | +5.8% | — | — | |
| Q3 2009 | +5.8% | — | — | |
| Q4 2009 | +5.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro